Long-term outcomes of neoadjuvant gefitinib in resectable stage II-IIIA non-small cell lung cancer: A phase II, prospective cohort study. Ma Z, Fu F, Zhang Y, Chen H, et al. Lung Cancer 2025;201:108457.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ma Z, Fu F, Zhang Y, Chen H, et al. Long-term outcomes of neoadjuvant gefitinib in resectable stage II-IIIA non-small cell lung cancer: A phase II, prospective cohort study. Lung Cancer 2025;201:108457.
PMID: 39999636